ProShares Ultra Nasdaq Biotechnology 2X Shares Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 13.21 K | $1.08 M | 105.25% | 1.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 8.10 K | $660.23 K | 102.50% | 0.84% |
| CITADEL ADVISORS LLC | 05/15/2026 | 7.61 K | $620.36 K | 100.00% | 0.79% |
| CAPITAL INVESTMENT ADVISORS, LLC | 04/17/2026 | 6.00 K | $488.73 K | 0.00% | 0.62% |
| CITADEL ADVISORS LLC | 05/15/2026 | 5.90 K | $480.90 K | 20.41% | 0.61% |
| KAIZEN FINANCIAL STRATEGIES | 05/01/2026 | 5.57 K | $482.60 K | 4.70% | 0.58% |
| PALUMBO WEALTH MANAGEMENT LLC | 05/12/2026 | 4.00 K | $326.03 K | 0.00% | 0.42% |
| CSENGE ADVISORY GROUP | 04/30/2026 | 2.86 K | $232.79 K | 100.00% | 0.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 2.50 K | $203.78 K | 100.00% | 0.26% |
| TOTH FINANCIAL ADVISORY CORP | 04/16/2026 | 997 | $81.26 K | 0.00% | 0.10% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 982 | $80.04 K | 4.69% | 0.10% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 696 | $56.73 K | 0.00% | 0.07% |
| PNC FINANCIAL SERVICES GROUP, INC. | 05/08/2026 | 500 | $40.75 K | 0.00% | 0.05% |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 05/11/2026 | 373 | $30.40 K | 100.00% | 0.04% |
| DESTINY WEALTH PARTNERS, LLC | 05/11/2026 | 270 | $22.01 K | 100.00% | 0.03% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 250 | $20.38 K | 0.00% | 0.03% |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 05/05/2026 | 198 | $16.00 K | 0.00% | 0.02% |
| TRUVESTMENTS CAPITAL LLC | 05/13/2026 | 125 | $10.19 K | 0.00% | 0.01% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 62 | $5.05 K | 416.67% | 0.01% |
| TD WATERHOUSE CANADA INC. | 05/12/2026 | 50 | $4.12 K | 100.00% | 0.01% |
| AXIOM INVESTMENT MANAGEMENT LLC | 05/26/2026 | 50 | $4.08 K | 100.00% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 50 | $4.08 K | -5.66% | 0.01% |
| WHITTIER TRUST CO | 04/28/2026 | 15 | $1.22 K | -80.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 1 | $156 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 1 | $89 | -50.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 1 | $82 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 0 | $0 | -100.00% | 0.00% |
ProShares Ultra Nasdaq Biotechnology 2X Shares institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of ProShares Ultra Nasdaq Biotechnology 2X Shares. The most heavily invested institutionals were:
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 13,212
CITADEL ADVISORS LLC: 7,611
Capital Investment Advisors, LLC: 5,996
Kaizen Financial Strategies: 5,565
Palumbo Wealth Management LLC: 4,000
Csenge Advisory Group: 2,856
4.57% of ProShares Ultra Nasdaq Biotechnology 2X Shares stock is owned by institutional investors.
Institutional investors have bought a total of 153.39 K shares in the last 24 months. This purchase volume represents approximately $12.87 M in transactions.